Notwithstanding the absence of a correlation between the extent of EZH2 expression and clinical parameters under consideration, it is evident that the majority of the evaluated cSCC tumor tissue samples exhibited EZH2 expression. The gene discussed is EZH2; the disease is neoplasm.